AC Immune SA ACIU:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:09 PM EDT
3.34UNCH (UNCH)
Volume
879
Close
3.34quote price arrow up+0.18 (+5.70%)
Volume
491,380
52 week range
1.90 - 5.14
Loading...
  • Open3.19
  • Day High3.37
  • Day Low3.09
  • Prev Close3.16
  • 52 Week High5.14
  • 52 Week High Date12/28/23
  • 52 Week Low1.90
  • 52 Week Low Date06/23/23

Key Stats

  • Market Cap331.321M
  • Shares Out99.20M
  • 10 Day Average Volume3.87M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change-33.2

KEY STATS

  • Open3.19
  • Day High3.37
  • Day Low3.09
  • Prev Close3.16
  • 52 Week High5.14
  • 52 Week High Date12/28/23
  • 52 Week Low1.90
  • 52 Week Low Date06/23/23
  • Market Cap331.321M
  • Shares Out99.20M
  • 10 Day Average Volume3.87M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change-33.2

RATIOS/PROFITABILITY

  • EPS (TTM)-0.76
  • P/E (TTM)-4.38
  • Fwd P/E (NTM)-5.24
  • EBITDA (TTM)-56.562M
  • ROE (TTM)-32.90%
  • Revenue (TTM)16.285M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-366.41%
  • Debt To Equity (MRQ)2.18%

EVENTS

  • Earnings Date08/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AC Immune SA

 

Profile

MORE
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative...
Douglas Williams Ph.D.
Independent Chairman of the Board
Andrea Pfeifer Ph.D.
Chief Executive Officer, Co-Founder, Director
Piergiorgio Donati
Chief Technical Operations Officer
Christopher Roberts
Chief Financial Officer, Vice President - Finance
Address
EPFL Innovation Park, Building B
Lausanne
1015
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
XOMA
XOMA Corp
25.90+0.87+3.48%
MGTX
MeiraGTx Holdings PLC
5.50-0.04-0.72%
PYXS
Pyxis Oncology Inc
4.00-0.19-4.53%
PGEN
Precigen Inc
1.39UNCHUNCH
VRCA
Verrica Pharmaceuticals Inc
8.77+0.07+0.80%